Chief Biotechnology Officer, VP, Robin and Jack Ross Chair of Bioelectronic Medicine and Neuroimmunology, Head of Intellectual Asset Management @NorthwellHealth

Joined February 2015
510 Photos and videos
Pinned Post
Yes, it’s called the nervous system 😉
Did you know that the body has a way of keeping the immune system in check?
5
8
114
38,770
Brian S. Kim reposted
Today, I’m especially grateful to live and work in a country that continues to invest in science, cancer research and biotech innovation. America’s commitment to discovery has helped turn bold ideas into lifesaving treatments for patients around the world. We are fortunate to do this work here, and even more fortunate to do it alongside researchers, clinicians, entrepreneurs and patients who believe progress is possible. Wishing everyone a safe and meaningful Independence Day. 🎆 #FourthOfJuly
1
6
27
1,306
Happy 250th Birthday to America! As the child of Korean immigrants who rebuilt their lives after a devastating war, I am deeply grateful for the extraordinary opportunities this country has provided. Although I was born in Yonkers, New York, I grew up in Alaska—the “Last Frontier.” In many ways, they are opposites, yet both embody something profoundly American: places where people come seeking a better life, where reinvention is possible, and where second chances are real. As my mother often says, what makes this country unique is that it places far less weight on where you come from or the mistakes you’ve made, and instead gives you the freedom to ask for what you want and pursue it. That level of openness and possibility is rare. Here’s to another 250 years of opportunity, prosperity, and humanity in a truly remarkable nation.
5
27
1,340
Brian S. Kim reposted
You're going to win, don't worry about the when
174
945
7,200
164,722
We’re wired to fixate on short‑term failure; the only real long‑term failure is never being able to look past it.
8
1,046
Brian S. Kim reposted
We’re excited to welcome Dr. Joni Rutter, Director of NCATS (National Center for Advancing Translational Sciences), as our Keynote Speaker at #CatalystNYC! As the head of @ncats_nih_gov, Dr. Rutter leads efforts to accelerate translational research, helping to turn laboratory results into real treatments. Rutter previously led the Division of Neuroscience and Behavior at @NIDAnews and ran scientific programs for the All of Us Research Program. Request your invite to Catalyst NYC here: luma.com/66yycaak
1
8
29
1,300
Today is my first day at Feinstein Institutes at @NorthwellHealth. I am joining the bioelectronic medicine and neuroimmunology legend @KevinJTraceyMD to make transformative changes not just to science and medicine, but how biotech can be done in an integrated healthcare system. Over the past 12 years, I’ve been lucky to work at the intersection of immunology, neuroscience, dermatology, allergy, and drug development inside major academic medical centers. That experience keeps revealing the same uncomfortable truth: our systems still struggle to support physician‑scientists who also build companies and turn ideas into products. My next chapter is about fixing that from a health‑system biotech vantage point - treating IP as core strategy, building real bridges from lab to clinic, and intentionally cultivating the “weird” careers: founders, C‑suite physician‑scientists, translational obsessives. If you’re working on the next generation of biomedical ecosystems, I'd love to connect.
6
8
105
11,003
One final work dinner with @Michel_Enamorad and Hongzhen Hu! I was incredibly blessed to work with two of the best colleagues, scientists, and human beings. Thank you guys. Note: Hongzhen and his perfect Mona Lisa pose. The journey continues!
1
1
33
3,271
For the record, I am still bullish on MRGPRX2 - maybe not in CSU - but definitely in a couple other indications. This does not take away from the biology and my clinical conviction. fiercebiotech.com/biotech/ev…
1
8
1,709
Here we go again! This preprint in @ResearchHub @researchsquare was reviewed in @Nature, revised, and, of course, a few more comments received, so under re-revision. @qedScience gave this original submission an even higher qualitative metric but still a top 1% score. So far both of our high profile submission/acceptances are concordant in terms of perceived quality, novelty, etc. We are now at N = 2 and it's starting to stack up. @ZhennWang @OdedRechavi
4
3
31
9,969
Brian S. Kim reposted
Peer reviewers keep science honest, but they were never paid for it. Now, peer reviewers get paid $150 for every eligible review on @ResearchHub. If you’re already reviewing papers, you might as well get paid for it: researchhub.com/earn
1,401 peer reviews were completed on @ResearchHub in Q1 🚀 On ResearchHub, experts earn $150 in $RSC for reviewing preprints and preregistered proposals. Reviewers shouldn't have to work for free. Get paid for your expertise.
1
10
41
3,148
The power of this is that unlike manual peer review which does not inform the next batch of reviews, in principle, it is improving over time as a system. It’s not about whether you agree with it or not. If people find it useful, it’ll scale. If not, it’ll fizzle. It’s not propped up by a manual prestige factory. As my friend George says, “you can’t eat a prestige sandwich”.
For life sciences companies, the question is not just: “What does the literature say?” It is: “Is this evidence strong enough to support the next decision?” Target validation. Biomarker development. Study design. Go / no-go. That is where QED Score matters.
7
16,849
Our preprint in @CellCellPress Sneak Peek in @SSRN got a 99 on the @qedScience score @OdedRechavi. This was before revisions. The revised manuscript is now accepted at @ImmunityCP. Very interesting @rofu47!
5
5
35
12,438
Completely agree. Never before in my career have I experienced such a collision of science and engineering of new technologies as today. The future (and present) is incredibly bright for the development of cures.
My colleague Chris Boshoff, who leads R&D, is featured in @sciam on the state of American science. He calls it extraordinary, and accelerating. He's right. We're living through a scientific renaissance, and I'm optimistic about what American innovation can do for patients. scientificamerican.com/artic…
1
2
26
7,823
Produce knowledge to develop cures. Everything else is noise.
5
9
64
4,593
After almost five meaningful years at the @IcahnMountSinai, I’ll be wrapping up my time here at the end of June and closing this chapter of my academic career. I’m deeply grateful to my colleagues, trainees, collaborators, and leaders at Mount Sinai for the opportunities to build programs together and push the science of neuroimmunology and care of inflammatory skin (and other) disease forward — it has been a privilege to grow alongside such a talented community. In July, I’ll be joining the Feinstein Institutes for Medical Research & @NorthwellHealth as the inaugural Chief Biotechnology Officer, focusing on building new bridges between discovery, clinical research, and biotech across the health system. I’m excited about the chance to help accelerate translational science at scale and to work with new partners across academia, industry, and venture. My lab will continue to focus on foundational science in neuroimmunology. More details soon. To everyone I’ve had the chance to work with so far — thank you. I’m looking forward to staying in touch, finding new ways to collaborate, and continuing to advance the field together from this new perch.
35
7
278
46,055
Congrats @jeffyfish9 !
We’re excited to share that ResearchHub Foundation President, Jeffrey Koury, has been named a founding member of Nucleate’s new Leadership Council. @NucleateHQ is a nonprofit organization that has helped thousands of scientists, founders, and innovators turn ideas into impact. Its new Leadership Council brings together leaders across biotech, academia, and entrepreneurship to help support the next generation of science. We’re proud to see @jeffyfish9 contributing to that mission alongside an exceptional group of leaders. Congratulations, Jeff! 🎉 Read Nucleate’s announcement ↓ nucleatehq.medium.com/introd…
10
3,205
I have known Matt for a long time. One of my favorite dermatologists. I had no idea he was so agile on social media. He will have a million followers is my prediction.
I was wrong about the Midjourney ultra-sound scanner. Well, maybe not wrong, but at a minimum I missed something obvious because I was thinking like a doctor who's been practicing for 25 years. And I didn't explain my point well. First, where I was wrong: All historical precendent that showed that widespread screening imaging is net neutral or harmful was imaging that was expensive, inconvenient, gated by physicians and couldn't practically be repeated frequently short term. If the Midjourney ultrasound is high resolution, harmless, inexpensive and convenient, people can get an initial scan, then if there are abnormalities concerning for cancer, they can get weekly follow up scans to see if it's growing/changing, and if it's not, they can leave it alone. In retrospect, that is obvious but it never occurred to me. Now, you'd assume that that approach would have to lead to it being useful and saving lives, and it probably will. But we won't really know it does until we have a couple years of data. Lots of things that seem obvious in medicine end up being wrong once we collect data. Second, what I didn't explain well: It's not that I think non-doctors are 'too dumb' to use the results effectively. Its that historically it was literally impossible to use the results effectively, and that is super, super counterintuitive. It seems obvious that finding stuff early is beneficial, but experience has shown that it isn't. Here's why: The vast majority of abnormalities (i.e. possible cancer) isn't cancer - like over 90% of them, ends up being harmless - something thay your body could have handled on it's own. But the only way to find out was to have invasive, risky procedures to biopsy or remove what was found. And overall, the side effects from all the risky, invasive procedures to track down the over 90% of stuff that was harmless equal or outweigh the benefit from removing the less than 10% of stuff that wasn't harmless. If the MIdjourney device can be repeated frequently, like weekly, at a low cost and is harmless, it could negate the need for the risky, invasive procedures. Not saying it will, but it seems like it could and I confidently posted yesterday that it was a bad idea. I was wrong to confidently post that.
1
10
4,972
AI transforms what was traditionally “luck”into repeatable leverage for domain experts.
2
780
Biology is not physics, clinical trials are not biology, regulatory is not a didactic clinical trial, but a human process. The part AI will revolutionize first is biology, which we have been waiting decades to see. But the bottlenecks remain human, all too human.
1
5
1,560
Don’t chase easy, accept the hard, and everything compounds.
1
11
1,672